1
|
Escudier B, Porta C, Schmidinger M,
Rioux-Leclercq N, Bex A, Khoo V, Grunwald V, Gillessen S and
Horwich A; ESMO Guidelines Committee, : Renal cell carcinoma: ESMO
Clinical Practice Guidelines for diagnosis, treatment and
follow-up. Ann Oncol. 30:706–720. 2019. View Article : Google Scholar : PubMed/NCBI
|
2
|
Siegel RL, Miller KD, Fuchs HE and Jemal
A: Cancer statistics, 2022. CA Cancer J Clin. 72:7–33. 2022.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Flippot R, Comperat E, Tannir NM and
Malouf GG: Papillary renal cell carcinoma: A family portrait. Eur
Urol. 73:79–80. 2018. View Article : Google Scholar : PubMed/NCBI
|
4
|
Akhtar M, Al-Bozom IA and Al Hussain T:
Papillary renal cell carcinoma (PRCC): An update. Adv Anat Pathol.
26:124–132. 2019. View Article : Google Scholar : PubMed/NCBI
|
5
|
Ljungberg B, Campbell SC, Choi HY, Jacqmin
D, Lee JE, Weikert S and Kiemeney LA: The epidemiology of renal
cell carcinoma. Eur Urol. 60:615–621. 2011. View Article : Google Scholar : PubMed/NCBI
|
6
|
Thyavihally YB, Mahantshetty U,
Chamarajanagar RS, Raibhattanavar SG and Tongaonkar HB: Management
of renal cell carcinoma with solitary metastasis. World J Surg
Oncol. 3:482005. View Article : Google Scholar : PubMed/NCBI
|
7
|
McAchran SE, Williams DH and MacLennan GT:
Renal cell carcinoma metastasis to the bladder. J Urol.
184:726–727. 2010. View Article : Google Scholar : PubMed/NCBI
|
8
|
Liem EIML, Baard J, Cauberg ECC, Bus MTJ,
de Bruin DM, Laguna Pes MP, de la Rosette JJMCH and de Reijke TM:
Fluorescence in situ hybridization as prognostic predictor of tumor
recurrence during treatment with Bacillus Calmette-Guérin therapy
for intermediate- and high-risk non-muscle-invasive bladder cancer.
Med Oncol. 34:1722017. View Article : Google Scholar : PubMed/NCBI
|
9
|
Matsumoto K, Hayakawa N, Nakamura S and
Oya M: Bladder metastasis from renal cell carcinoma: Retrospective
analysis of 65 reported cases. Clin Exp Metastasis. 32:135–141.
2015. View Article : Google Scholar : PubMed/NCBI
|
10
|
Gajasinghe DG, Nazeer I, Maddumage HP,
Perera C and Abeygunasekera AM: Metachronous bladder metastases of
a type 2 papillary renal cell carcinoma: A case report and review
of the literature. World J Surg Oncol. 14:2192016. View Article : Google Scholar : PubMed/NCBI
|
11
|
Babar M, Hamdani S, Liu C, Vedula J and
Schnapp DS: Metachronous renal cell carcinoma with metastasis to
the urinary bladder, and distant organs, 28 years after radical
nephrectomy: A case report. BMC Urol. 19:1362019. View Article : Google Scholar : PubMed/NCBI
|
12
|
Raviv S, Eggener SE, Williams DH, Garnett
JE, Pins MR and Smith ND: Long-term survival after ‘drop
metastases’ of renal cell carcinoma to the bladder. Urology.
60:6972002. View Article : Google Scholar : PubMed/NCBI
|
13
|
Chung HK, Silva LN, Pereira MA, Catelli R
and Freitas RJ: Giant Abdominal Mass: Papillary Renal Cell
Carcinoma with Metastases to the Bladder, Omentum and Perigastric
tissue. J Surg Oncol. 2674–3000. 2020.
|
14
|
Hsieh PY, Hung SC, Li JR, Wang SS, Yang
CK, Chen CS, Lu K, Cheng CL and Chiu KY: The effect of
metastasectomy on overall survival in metastatic renal cell
carcinoma: A systematic review and meta-analysis. Urol Oncol.
39:422–430. 2021. View Article : Google Scholar : PubMed/NCBI
|
15
|
Abern MR, Owusu RA, Anderson MR,
Rampersaud EN and Inman BA: Perioperative intravesical chemotherapy
in non-muscle-invasive bladder cancer: A systematic review and
meta-analysis. J Natl Compr Canc Netw. 11:477–484. 2013. View Article : Google Scholar : PubMed/NCBI
|
16
|
Kavolius JP, Mastorakos DP, Pavlovich C,
Russo P, Burt ME and Brady MS: Resection of metastatic renal cell
carcinoma. J Clin Oncol. 16:2261–2266. 1998. View Article : Google Scholar : PubMed/NCBI
|
17
|
De Groote R, Larcher A, Goossens M,
Hendrik R, Kris VS, De Coninck V, De Naeyer G, Schatteman P,
D'Hondt F and Mottrie A: Metachronous metastasis of renal cell
carcinoma to the urinary bladder: A case report. Ther Adv Urol.
10:29–32. 2017. View Article : Google Scholar : PubMed/NCBI
|
18
|
Motzer RJ, Hutson TE, Cella D, Reeves J,
Hawkins R, Guo J, Nathan P, Staehler M, de Souza P, Merchan JR, et
al: Pazopanib versus sunitinib in metastatic renal-cell carcinoma.
N Engl J Med. 369:722–731. 2013. View Article : Google Scholar : PubMed/NCBI
|
19
|
Kaelin WG Jr: The von Hippel-Lindau tumour
suppressor protein: O2 sensing and cancer. Nat Rev Cancer.
8:865–873. 2008. View
Article : Google Scholar : PubMed/NCBI
|
20
|
D'Avella C, Abbosh P, Pal SK and Geynisman
DM: Mutations in renal cell carcinoma. Urol Oncol. 38:763–773.
2020. View Article : Google Scholar : PubMed/NCBI
|
21
|
Sharma V, Miest TS, Juvet TS, Toussi A,
Packiam V, Chamie K, Matin SF, Boorjian SA, Thompson RH, Frank I,
et al: The impact of upper tract urothelial carcinoma diagnostic
modality on intravesical recurrence after radical
nephroureterectomy: A single institution series and updated
meta-analysis. J Urol. 206:558–567. 2021. View Article : Google Scholar : PubMed/NCBI
|
22
|
Campbell MT, Matin SF, Tam AL, Sheth RA,
Ahrar K, Tidwell RS, Rao P, Karam JA, Wood CG, Tannir NM, et al:
Pilot study of Tremelimumab with and without cryoablation in
patients with metastatic renal cell carcinoma. Nat Commun.
12:63752021. View Article : Google Scholar : PubMed/NCBI
|